98%
921
2 minutes
20
Transmission dynamics and the maintenance of mammarenaviruses in nature are poorly understood. Using metagenomic next-generation sequencing (mNGS) and RT-PCR, we investigated the presence of mammarenaviruses and co-infecting helminths in various tissues of 182 rodents and 68 other small mammals in riverine and non-riverine habitats in Zambia. The Luna virus (LUAV) genome was the only mammarenavirus detected (7.7%; 14/182) from . Only one rodent from the non-riverine habitat was positive, while all six foetuses from one pregnant rodent carried LUAV. LUAV-specific mNGS reads were 24-fold higher in semen than in other tissues from males. Phylogenetically, the viruses were closely related to each other within the LUAV clade. Helminth infections were found in 11.5% (21/182) of . LUAV-helminth co-infections were observed in 50% (7/14) of virus-positive rodents. Juvenility (OR = 9.4; = 0.018; 95% CI: 1.47-59.84), nematodes (OR = 15.5; = 0.001; 95% CI: 3.11-76.70), cestodes (OR = 10.8; = 0.025; 95% CI: 1.35-86.77), and being male (OR = 4.6; = 0.036; 95% CI: 1.10-18.90) were associated with increased odds of LUAV RNA detection. The role of possible sexual and/or congenital transmission in the epidemiology of LUAV infections in rodents requires further study, along with the implications of possible helminth co-infection.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697851 | PMC |
http://dx.doi.org/10.3390/pathogens11111345 | DOI Listing |
Nat Commun
August 2025
Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA.
Eastern equine encephalitis virus (EEEV) is a mosquito-transmitted alphavirus that can cause severe encephalitis in humans and horses with a high case fatality rate. There are no licensed EEEV vaccines or therapeutics for human use, warranting the need to better understand the human immune response against EEEV. Here we present a cryo-EM reconstruction of the chimeric virus, Sindbis (SINV)/EEEV, in complex with a potently neutralizing and efficacious intact human IgG1 antibody in a mouse model of infection and disease.
View Article and Find Full Text PDFPLoS One
August 2025
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos PDR.
Introduction: Dengue fever is a growing global concern with an estimated 100-400 million infections every year and rising mortality over the past decade. In 2017, 40,000 deaths were attributed to dengue. Real-time reverse transcription PCR (RT-qPCR) is the gold standard technique to detect dengue virus (DENV) during the acute phase of the infection.
View Article and Find Full Text PDFNat Commun
August 2025
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Reports of secondary malignancies after chimeric antigen receptor (CAR)-T and possible CAR-T derived malignant transformation necessitate caution. Here we describe a patient with diffuse large B-cell lymphoma who developed new lymphadenopathy 2.5 years after CAR-T in the context of COVID-19 infection with histopathologic features consistent with T-cell lymphoma (TCL).
View Article and Find Full Text PDFTheriogenology
December 2025
Laboratorio de Virología Veterinaria, Instituto de Innovación para la Producción Agropecuaria y el Desarrollo Sostenible, Instituto Nacional de Tecnología Agropecuaria (INTA) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Balcarce, Argentina. Electronic address: galtam
Bovine Viral Diarrhea Virus (BVDV) and anti-BVDV antibodies have been detected in ovarian follicular fluid of infected cows. The aim of this study was to assess both the frequency of BVDV detection and the prevalence of anti-BVDV antibodies in pooled follicular fluid obtained from slaughterhouse ovaries for in vitro embryo production. Additionally, we sought to determine whether specific antibodies present in these samples are able to neutralize different BVDV strains.
View Article and Find Full Text PDFCell Rep
August 2025
Integral Molecular, Inc., Philadelphia, PA, USA. Electronic address:
The development of a Zika virus (ZIKV) vaccine is complicated by the high homology between ZIKV and dengue virus (DENV) envelope (E) proteins, resulting in immunological cross-reactivity that can exacerbate disease through antibody-dependent enhancement (ADE). Here, we screen 121 anti-DENV monoclonal antibodies (mAbs) for cross-reactivity with ZIKV E proteins. We identify 70 cross-reactive mAbs, 66 of which have epitopes that included at least one of seven E protein residues conserved among DENV1-DENV4 and ZIKV (R73, E79, W101, L107, F108, K110, and W212), establishing these residues as the key determinants of DENV-ZIKV cross-reactivity.
View Article and Find Full Text PDF